Logo image of IPX

IPERIONX LTD - ADR (IPX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IPX - US44916E1001 - ADR

33.8 USD
+1.43 (+4.42%)
Last: 11/28/2025, 7:39:47 PM
33.085 USD
-0.71 (-2.12%)
After Hours: 11/28/2025, 7:39:47 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IPX. IPX was compared to 154 industry peers in the Metals & Mining industry. IPX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IPX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IPX has reported negative net income.
In the past year IPX has reported a negative cash flow from operations.
In the past 5 years IPX always reported negative net income.
IPX had a negative operating cash flow in each of the past 5 years.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of IPX (-18.86%) is worse than 76.62% of its industry peers.
IPX has a worse Return On Equity (-20.70%) than 70.13% of its industry peers.
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

6

2. Health

2.1 Basic Checks

IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPX has more shares outstanding than it did 1 year ago.
IPX has more shares outstanding than it did 5 years ago.
IPX has a worse debt/assets ratio than last year.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

IPX has an Altman-Z score of 65.30. This indicates that IPX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 65.30, IPX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
IPX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, IPX is in the better half of the industry, outperforming 69.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 65.3
ROIC/WACCN/A
WACC9.4%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

A Current Ratio of 11.80 indicates that IPX has no problem at all paying its short term obligations.
The Current ratio of IPX (11.80) is better than 91.56% of its industry peers.
IPX has a Quick Ratio of 11.80. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
IPX has a better Quick ratio (11.80) than 91.56% of its industry peers.
Industry RankSector Rank
Current Ratio 11.8
Quick Ratio 11.8
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.37% over the past year.
The Revenue has grown by 10.41% in the past year. This is quite good.
IPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 78.65% yearly.
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, IPX will show a very strong growth in Earnings Per Share. The EPS will grow by 58.70% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.31%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y58.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

IPX's earnings are expected to grow with 31.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y31.76%

More info and screens

0

5. Dividend

5.1 Amount

IPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IPERIONX LTD - ADR

NASDAQ:IPX (11/28/2025, 7:39:47 PM)

After market: 33.085 -0.71 (-2.12%)

33.8

+1.43 (+4.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-29 2025-09-29
Earnings (Next)03-10 2026-03-10
Inst Owners37.11%
Inst Owner Change-58.86%
Ins Owners13.91%
Ins Owner ChangeN/A
Market Cap1.13B
Revenue(TTM)546.00K
Net Income(TTM)-21.84M
Analysts80
Price Target39.6 (17.16%)
Short Float %1.21%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-24.85%
PT rev (3m)-3.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)28.86%
EPS NY rev (3m)17.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2077.8
P/FCF N/A
P/OCF N/A
P/B 10.75
P/tB 12.41
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS0.02
BVpS3.14
TBVpS2.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2601.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.8
Quick Ratio 11.8
Altman-Z 65.3
F-Score3
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.1%
Cap/Sales(5y)2901.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-1.31%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y58.7%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.67%
EBIT Next 3Y42.94%
EBIT Next 5Y66.14%
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.9%
OCF growth 3YN/A
OCF growth 5YN/A

IPERIONX LTD - ADR / IPX FAQ

What is the ChartMill fundamental rating of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IPX.


Can you provide the valuation status for IPERIONX LTD - ADR?

ChartMill assigns a valuation rating of 1 / 10 to IPERIONX LTD - ADR (IPX). This can be considered as Overvalued.


Can you provide the profitability details for IPERIONX LTD - ADR?

IPERIONX LTD - ADR (IPX) has a profitability rating of 0 / 10.


How financially healthy is IPERIONX LTD - ADR?

The financial health rating of IPERIONX LTD - ADR (IPX) is 6 / 10.